Peak Financial Advisors’s CytomX Therapeutics CTMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.26M Buy
+462,061
New +$1.54M 0.54% 44

Other funds holding CTMX

Peak Financial Advisors's CTMX Position: Q3 2026 in Review

Peak Financial Advisors opened a new position in CytomX Therapeutics (CTMX) in Q3 2026: 462,061 shares worth $1.26M. The stake represents 0.54% of the portfolio and ranks #44 among its holdings.

193 funds tracked by Wall St. Rank hold CTMX as of Q3 2026.

  • Peak Financial Advisors held 462,061 shares of CytomX Therapeutics worth $1.26M as of Q3 2026.
  • CytomX Therapeutics was a new Peak Financial Advisors position in Q3 2026.
  • CytomX Therapeutics made up 0.54% of Peak Financial Advisors's portfolio in Q3 2026, its #44 holding.
  • 193 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q3 2026.

Based on Peak Financial Advisors's 13F filing for Q3 2026, filed 28 Oct 2026.